File(s) not publicly available
Corporate reputation management in the US pharmaceutical industry
report
posted on 2023-07-26, 16:50 authored by Kimberly Goldstein, John Doorley, Paul TurnerThe reputations of firms may be linked to the degree to which they have formal reputation management programs. To examine that hypothesis the authors surveyed firms in the U.S. pharmaceutical industry where reputation is a highly visible challenge. We compared the reputation measurement and management efforts of the most admired firms with those of less admired firms. The data indicate a positive correlation in five areas – that is, between reputation and having an ongoing reputation measurement program; having an active reputation management program; having a formal reputation management plan; having an individual or unit charged with responsibility for coordinating / overseeing reputation management; and having the chief communication officer as a member of the company‘s executive committee.
History
Refereed
- Yes
Publisher
Institute for Public RelationsPlace of publication
Gainesville, FLLanguage
- other
Report type
- Other
Official URL
Legacy posted date
2011-05-26Legacy Faculty/School/Department
ARCHIVED Lord Ashcroft International Business School (until September 2018)Usage metrics
Categories
No categories selectedKeywords
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC